Why can't we develop COVID-19 treatments faster?

Item request has been placed!

Item request cannot be made.

Processing Request

Read More Get Citations

Author(s): KOMAROFF, ANTHONY L.
Source:
Harvard Health Letter. Sep2020, Vol. 45 Issue 11, p2-2. 3/4p. 1 Color Photograph.

Additional Information
- Subject Terms:
  ANTIVIRAL agents; DRUG efficacy; MEDICAL emergencies; PATIENT safety; PUBLIC health; UNITED States. Food & Drug Administration; DRUG development; DRUG approval; DEXAMETHASONE; COVID-19
- Abstract:
  The article presents answer to the question related to COVID-19 is an unprecedented public health emergency, doctors efforts in faster developing drugs for it that are effective and safe.